Research Scientist (I) in nanopharmaceuticals

Natheer Haddad is a PhD student at the University of Nottingham, School of Medicine, working within the Biodiscovery Institute. Awarded the prestigious UKRI-funded BBSRC DTP scholarship, Haddad's research focuses on developing advanced drug delivery systems for targeted cancer therapy. By leveraging cutting-edge technologies, the project aims to design novel delivery mechanisms that improve the precision and efficacy of cancer treatments. Prior to pursuing doctoral studies, Haddad gained industrial experience in nanoparticle-based gene delivery, contributing to the development of innovative solutions within the pharmaceutical sector. This background provides a strong foundation for Haddad's current research, which integrates expertise in nanoparticle engineering and cancer biology to address critical challenges in targeted therapies. Haddad's research interests include cancer biology, advanced drug delivery systems, biomaterials, targeted cancer therapeutics, and tumor-specific therapies.